Krystal Biotech Inc. (KRYS)
NASDAQ: KRYS
· Real-Time Price · USD
137.50
0.04 (0.03%)
At close: Sep 11, 2025, 10:30 AM
Krystal Biotech Revenue
Krystal Biotech reported an annual revenue of $290.51M, reflecting a 473.02% growth. For the quarter ending June 30, 2025, Krystal Biotech generated $96.04M in revenue.
Revenue (ttm)
290.51M
Revenue Growth
473.02%
Price / Sales Ratio
15.42
Revenue / Employee
1.06M
Employees
275
Market Cap
3.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 290.51M | +473.02% |
| Dec 31, 2023 | 50.7M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | -100.00% |
| Dec 31, 2018 | 1.03M | +Infinity% |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |